Analysis of the IgG subclass profile and IgG sum-total discrepancy in COVID-19 convalescent plasma donors: A single-centre prospective cohort study

Transfus Apher Sci. 2023 Feb;62(1):103527. doi: 10.1016/j.transci.2022.103527. Epub 2022 Aug 26.

Abstract

Introduction: Although IgG1 and IgG3 have been shown to be the dominant subclasses in the acute phase of SARS-CoV-2 infection, little is known about the distribution of IgG subclasses during the recovery phase of COVID-19. The aim of the study was to analyze the profile of IgG subclasses in COVID-19 convalescent plasma donors.

Methods: A total of 36 convalescent plasma donors were included in the analysis. IgG and IgG subclass levels were measured using a nephelometric assay in plasma samples obtained directly from the plasma container.

Results: Although there was no significant difference in the concentration of IgG subclasses between the study and control groups, the contribution of IgG1 to the total IgG pool between the study and control groups was statistically significant (p = 0.0478). In addition, there was a discrepancy between the total IgG and IgG sum values in the study group, exceeding 15 % in 19,4 % of samples (n = 7), while in the control group no samples with a sum/ total IgG difference > 15 % were observed.

Conclusions: The selective affinity of the IgG1 subclass for the polyclonal anti-IgG reagent may interfere with the determination of total IgG and should be considered when interpreting the results of enzyme immunoassays DATA AVAILABILITY: The data that support the findings of this study are available on request from the corresponding author.

Keywords: COVID-19; Convalescent plasma; IgG; Immunoglobulin G; SARS-CoV-2.

MeSH terms

  • COVID-19 Serotherapy
  • COVID-19* / therapy
  • Humans
  • Immunoglobulin G
  • Prospective Studies
  • SARS-CoV-2

Substances

  • Immunoglobulin G